October 2005 – The CenterWatch Monthly : PDF
Contract/Budget Process Top Study Delay
In an unprecedented result, respondents to the 2005 Thomson CenterWatch 2005 Survey of Investigative Sites in the U.S. have rated the contract and budget negotiation and approval process the number one factor most often causing study delays. The contract and budget negotiation and approval process causes delay not only in study startup but also in patient recruitment and enrollment, the major focus area of the clinical research industry in terms of reducing drug development times.
Staffing Companies Staff up
Clinical staffing companies have seen continued growth as drug companies become more receptive to using these firms for supplying contract clinical staff. While staffing companies work with small- and medium-sized biopharmaceutical companies, usually supplying one or two contractors for a particular project, the majority of the contracts for large numbers of personnel are with major pharmaceutical companies.
Directives Create Legal Patchwork in EU
Harmonization seems a long way off from being achieved, creating a difficult legal patchwork for researchers to puzzle through.
Eye on: Breast Cancer
In the U.S., breast cancer causes 40,000 deaths each year. CenterWatch has identified a pipeline of 27 drugs in development for breast cancer.